Bbva Compass Bancshares Inc. decreased its position in shares of Danaher Corp. (NYSE:DHR) by 6.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,230 shares of the company’s stock after selling 1,117 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Danaher Corp. were worth $1,741,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the stock. Cribstone Capital Management LLC acquired a new stake in Danaher Corp. during the second quarter worth about $132,000. Monetary Management Group Inc. increased its stake in Danaher Corp. by 366.7% in the first quarter. Monetary Management Group Inc. now owns 1,400 shares of the company’s stock worth $133,000 after buying an additional 1,100 shares during the last quarter. Carnick & Kubik LLC acquired a new stake in Danaher Corp. during the first quarter worth about $171,000. Integrated Investment Consultants LLC acquired a new stake in Danaher Corp. during the second quarter worth about $179,000. Finally, Washington Trust Bank increased its stake in Danaher Corp. by 88.4% in the second quarter. Washington Trust Bank now owns 1,950 shares of the company’s stock worth $197,000 after buying an additional 915 shares during the last quarter. 75.74% of the stock is currently owned by institutional investors.
Danaher Corp. (NYSE:DHR) traded up 0.01% during mid-day trading on Friday, hitting $76.22. 2,222,262 shares of the stock were exchanged. Danaher Corp. has a 12-month low of $61.60 and a 12-month high of $82.64. The company has a 50 day moving average of $78.28 and a 200 day moving average of $76.77. The firm has a market cap of $52.63 billion, a P/E ratio of 15.16 and a beta of 1.13.
Danaher Corp. (NYSE:DHR) last issued its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.03. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. Danaher Corp.’s revenue was up 16.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.08 EPS. On average, equities analysts anticipate that Danaher Corp. will post $3.56 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $0.50 annualized dividend and a yield of 0.66%. Danaher Corp.’s dividend payout ratio (DPR) is currently 9.94%.
DHR has been the topic of a number of recent research reports. Jefferies Group upped their price target on shares of Danaher Corp. from $92.00 to $93.00 and gave the company a “buy” rating in a research note on Tuesday, July 26th. JPMorgan Chase & Co. reaffirmed a “buy” rating and set a $105.00 price target on shares of Danaher Corp. in a research note on Thursday, June 30th. Argus reaffirmed a “buy” rating and set a $90.00 price target (down previously from $110.00) on shares of Danaher Corp. in a research note on Thursday, July 28th. Morgan Stanley reaffirmed a “buy” rating and set a $86.00 price target on shares of Danaher Corp. in a research note on Wednesday, August 31st. Finally, Vetr raised shares of Danaher Corp. from a “hold” rating to a “buy” rating and set a $81.69 target price on the stock in a research note on Monday, September 12th. Eight equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $92.87.
In other Danaher Corp. news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the business’s stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the sale, the insider now directly owns 179,054 shares in the company, valued at $14,582,157.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Daniel L. Comas sold 96,446 shares of the business’s stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the sale, the chief financial officer now owns 215,716 shares in the company, valued at $17,447,110.08. The disclosure for this sale can be found here. 12.60% of the stock is currently owned by corporate insiders.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.